Menu

Jobs for Refugee Scientists

The European Commission has pledged to help find positions for researchers fleeing their home countries.

Oct 7, 2015
Kerry Grens

WIKIPEDIA, MSTYSLAV CHERNOVA new program called science4refugees, launched by the European Commission this week (October 5), intends to find jobs for displaced researchers by hooking them up with “refugee-welcoming organizations.”

“By matching refugees and asylum seekers who have a scientific background with European scientific institutions, the EU [European Union] will gain a huge diversity of new insight for our research, science and innovation, while taking practical steps in providing meaningful opportunities for a vastly talented, but greatly underprivileged, community,” European Commissioner for Research, Science, and Innovation, Carlos Moedas, said in a press release.

Kurt Deketelaere, secretary-general of the League of European Research Universities, told ScienceInsider that several universities are already on board, including the University of Strasbourg in France and the University of Leuven in Belgium.

Another organization, the U.K.-based Council for At-Risk Academics, is also providing aid to scientists who’ve fled from their homes. Executive Director Stephen Wordsworth told ScienceInsider that “anything that helps is welcome.” But, he added, “it’s unclear how many people can benefit” from the commission’s plan, which does not offer any preferential treatment for refugee candidates competing for jobs.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.